Mianyang Miaolinfen Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Mianyang Miaolinfen Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RXENOVELAIR. The owner is based in Mianyang, Sichuan.

Room B218-461 Building 2, Science and Technology City, New Area Innovation Center

Mianyang, Sichuan 621000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mianyang Miaolinfen Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Mianyang Miaolinfen Trading Co., Ltd. have?

Mianyang Miaolinfen Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Mianyang Miaolinfen Trading Co., Ltd. file in?

Mianyang Miaolinfen Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Mianyang Miaolinfen Trading Co., Ltd.'s most well-known trademarks?

Mianyang Miaolinfen Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as RXENOVELAIR. These are among 1 currently registered trademark in the portfolio.

What is Mianyang Miaolinfen Trading Co., Ltd.'s trademark registration success rate?

Mianyang Miaolinfen Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.